Correlation of human S100A12 (EN-RAGE) and high-sensitivity C-reactive protein as gingival crevicular fluid and serum markers of inflammation in chronic periodontitis and type 2 diabetes

Inflammation Research

Volumn 63, Issue 4, 2014, Pages 317-323

  Pradeep, A R ^a   Martande, Santosh S ^a   Singh, Sonender Pal ^a   Suke, Deepak Kumar ^a   Raju, Arjun P ^b   Naik, Savitha B ^a  

^a GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE   (India)

^b Bengaluru Medical College and Research Institute   (India)

Author keywords

Biomarkers; Chronic periodontitis; Diabetes mellitus; Gingival crevicular fluid; Inflammation

Indexed keywords

C REACTIVE PROTEIN; PROTEIN S 100; PROTEIN S100A12; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC PERIODONTITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; IMMUNOASSAY; IMMUNOTURBIDIMETRIC ANALYSIS; MALE; MEDIATOR RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHRONIC PERIODONTITIS; DIABETES MELLITUS, TYPE 2; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MIDDLE AGED; S100 PROTEINS;

EID: 84896542891     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-013-0703-3     Document Type: Article

References (35)

1. Holt SC, Ebersole JL. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the 'red complex', a prototype polybacterial pathogenic consortium in periodontitis. Periodontology. 2000;2005(38):72-122. (Pubitemid 43034324)
2. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontology. 2000;1997(14):33-53. (Pubitemid 127601170)
3. Miyasaki KT. The neutrophil: mechanisms of controlling periodontal bacteria. J Periodontol. 1991;62:761-74.
4. Winer N, Sowers JR. Epidemiology of diabetes. J Clin Pharmacol. 2004;44:397-405. (Pubitemid 38396785)
5. Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol. 2001;6:99-112.
6. Loe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care. 1993;16:329-34. (Pubitemid 23013872)
7. Taylor GW, Burt BA, Becker MP, et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin dependent diabetes mellitus. J Periodontol. 1996;67(10 Suppl): 1085-93. (Pubitemid 126613089)
8. Pietzsch J, Hoppmann S. Human S100A12: a novel key player in inflammation? Amino Acids. 2009;36:381-9.
9. Guignard F, Mauel J, Markert M. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochem J. 1995;309:395-401.
10. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta. 1999;1450: 191-231. (Pubitemid 29295473)
11. Yang Z, Tao T, Raftery MJ, Youssef P, Di Girolamo N, Geczy CL. Proinflammatory properties of the human S100 protein S100A12. J Leukoc Biol. 2001;69:986-94. (Pubitemid 32577902)
12. Yang Z, Yan WX, Cai H, et al. S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity. J Allergy Clin Immunol. 2007;119:106-14. (Pubitemid 46037791)
13. Yilmaz Y, Yonal O, Eren F, Atug O, Over Hamzaoglu H. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity. J Crohns Colitis. 2011;5:402-6.
14. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem. 1997;272:17810-4. (Pubitemid 27311222)
15. Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/ calgranulin polypeptides. Cell. 1999;97:889-901. (Pubitemid 29375048)
16. Foell D, Kane D, Bresnihan B, et al. Expression of the proinflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology. 2003;42:1383-9. (Pubitemid 37407031)
17. Foell D, Kucharzik T, Kraft T, et al. Neutrophil derived S100A12 (EN-RAGE) is strongly expressed in chronic active inflammatory bowel disease. Gut. 2003;52:847-53. (Pubitemid 36613492)
18. Foell D, Seeliger S, Vogl T, et al. Expression of S100A12 (ENRAGE) in cystic fibrosis. Thorax. 2003;58:613-7. (Pubitemid 36808133)
19. Heo SH, Choi YJ, Lee JH, Lee JM, Cho JY. S100A2 levels are related to human periodontitis. Mol Cells. 2011;32:445-50.
20. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol. 2001;72:1221-7. (Pubitemid 33607184)
21. Blüher M, Fasshauer M, Tönjes A, Kratzsch J, Schön MR, Paschke R. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. Exp Clin Endocrinol Diabetes. 2005;113:534-7. (Pubitemid 41585991)
22. Kosaki A, Hasegawa T, Kimura T, et al. Increased plasma S100A12 (EN-RAGE) levels in subjects with type 2 diabetes. J Clin Endocrinol Metab. 2004;89:5423-8. (Pubitemid 39518420)
23. Löe H. The gingival index, the plaque index and the retention index systems. J Periodontol. 1967;38(6 Suppl):610-6.
24. Glavind L, Löe H. Errors in the clinical assessment of periodontal destruction. J Periodontal Res. 1967;2:180-4.
25. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-63.
26. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care. 2011;34(Suppl 1):S11-61.
27. Löe H, Holm-Pedersen P. Absence and presence of fluid from normal and inflamed gingivae. Periodontics. 1965;149:171-7.
28. Pradeep AR, Raghavendra N, Sharma A, et al. Association of serum and gingival crevicular fluid visfatin concentration in periodontal health and disease with type 2 diabetes. J Periodontol. 2012;83:629-34.
29. Lalla E, Lamster IB, Stern DM, Schmidt AM. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities. Ann Periodontol. 2001;6:113-8.
30. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-Reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-34. (Pubitemid 32656163)
31. Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Fujii M, Tsuchihashi K, Goto H, Nakatani K, Yano Y. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1998;83:859-62. (Pubitemid 28496458)
32. Zinman B, Hanley AJ, Harris SB, Kwan J, Fantus IG. Circulating tumor necrosis factor-concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab. 1999;84:272-8. (Pubitemid 29036713)
33. Jokl R, Laimins M, Klein RL, Lyons TJ, Lopes-Virella MF, Colwell JA. Platelet plasminogen activator inhibitor 1 in patients with type II diabetes. Diabetes Care. 1994;17:818-23. (Pubitemid 24235499)
34. Wu CL, Chen FL. Evaluation of C-reactive protein levels in serum and gingival crevicular fluid in type 2 diabetes patients with periodontitis. Shanghai Kou Qiang Yi Xue. 2009;18:132-5 (Chinese).
35. Megson E, Fitzsimmons T, Dharmapatni K, Bartold PM. C-reactive protein in gingival crevicular fluid may be indicative of systemic inflammation. J Clin Periodontol. 2010;37:797-804.